• 5147 Citations
  • 30 h-Index
1988 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Matthew Peters is a Respiratory Physician and Head of Respiratory Medicine at Macquarie University and Concord Hospital. He holds academic appointments at Macquarie University and The University of Sydney. He has long had an interest in preventative health and was Chair of Action on Smoking and Health (ASH) for many years. He is a past President of the Thoracic Society of Australia and New Zealand. He has research interests in respiratory physiology and the pulmonary and cardiac responses to hypoxia.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Asthma Medicine & Life Sciences
Chronic Obstructive Pulmonary Disease Medicine & Life Sciences
Lung Medicine & Life Sciences
Smoking Cessation Medicine & Life Sciences
methionyl-leucyl-phenylalanine Medicine & Life Sciences
Inhalation Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Air Travel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma

Fricker, M., Gibson, P. G., Powell, H., Simpson, J. L., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Jenkins, C., Peters, M. J., Marks, G. B., Baraket, M. & Baines, K. J., 22 Jan 2019, In : Journal of Allergy and Clinical Immunology.

Research output: Contribution to journalArticleResearchpeer-review


Clinical use of epidermal growth factor receptor testing in patients with advanced lung cancer by physicians: survey of US and international patterns

Peters, M., Kim, E. S. & Hirsch, V., 1 Apr 2019, In : Journal of global oncology. 5, 5, p. 1-7 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Epidermal Growth Factor Receptor
Lung Neoplasms

Development of the International Severe Asthma Registry (ISAR): a modified Delphi study

Bulathsinhala, L., Eleangovan, N., Heaney, L. G., Menzies-Gow, A., Gibson, P. G., Peters, M., Hew, M., van Boven, J. F. M., Lehtimäki, L., van Ganse, E., Belhassen, M., Harvey, E. S., Perez de Llano, L., Maitland-van der Zee, A. H., Papadopoulos, N. G., FitzGerald, J. M., Porsbjerg, C., Canonica, G. W., Backer, V., Rhee, C. K. & 10 othersVerhamme, K. M. C., Buhl, R., Cosio, B. G., Carter, V., Price, C., Le, T., Stagno d'Alcontres, M., Gopalan, G., Tran, T. N. & Price, D., 1 Feb 2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 2, p. 578-588.e2 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Delphi Technique
Administrative Personnel
Disease Management

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

Busse, W. W., Bleecker, E. R., FitzGerald, J. M., Ferguson, G. T., Barker, P., Sproule, S., Olsson, R. F., Martin, U. J., Goldman, M. & BORA study investigators, 1 Jan 2019, In : The Lancet Respiratory Medicine. 7, 1, p. 46-59 14 p.

Research output: Contribution to journalArticleResearchpeer-review


Mepolizumab improves small airway function in severe eosinophilic asthma

Farah, C. S., Badal, T., Reed, N., Rogers, P. G., King, G. G., Thamrin, C., Peters, M. J. & Seccombe, L. M., 1 Mar 2019, In : Respiratory Medicine. 148, p. 49-53 5 p.

Research output: Contribution to journalArticleResearchpeer-review